FindTrial
Sign In

Evaluation of residual height and volume after thoracoscopic minimally invasive left atrial appendage clipping by 3D ultrasound

Evaluation of residual height and volume after thoracoscopic minimally invasive left atrial appendage clipping by 3D ultrasound

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067292
Enrollment
Unknown
Registered
2023-01-03
Start date
2023-01-03
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Experimental group:3D ultrasound evaluation of residual height and volume after thorascopic minimally invasive left atrial appendage clipping

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with atrial fibrillation who meet long-term OAC/NOAC conditions refuse to receive medication despite thorough medication notification; 2. Atrial fibrillation patients with long-term absolute contraindication of OAC/NOAC; 3. Patients with atrial fibrillation do not follow drug therapy; 4. Complex persistent atrial fibrillation; 5. Patients with recurrence after previous catheter ablation; 6. Patients with recurrent atrial fibrillation after surgical ablation.

Exclusion criteria

Exclusion criteria: 1. Severe diastolic dysfunction; 2. Left atrial thrombosis; 3. Patients with past heart surgery; 4. Extensive intrathoracic adhesion; 5. Patients with poor respiratory function and difficulty in tolerating anesthesia.

Design outcomes

Primary

MeasureTime frame
Left atrial appendage residual height;—

Countries

China

Contacts

Public ContactQian Yongjun

West China Hospital, Sichuan University

qianyongjun@scu.edu.cn+86 134 5851 2199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026